RG7351

From Wikipedia, the free encyclopedia
Jump to: navigation, search
RG7351
Systematic (IUPAC) name
?
Clinical data
Legal status ?
Identifiers
CAS number ?
ATC code ?
Chemical data
Formula ?
Mol. mass ?

RG7351 is a drug which acts as a presumably selective partial agonist of the trace amine-associated receptor 1 (TAAR1).[1] It is currently under early stage development by Hoffmann–La Roche for the treatment of major depressive disorder, and as of 2010, is in phase I clinical trials.[1]

See also[edit]

References[edit]

  1. ^ a b Francisco López-Muñoz; Cecilio Alamo (9 September 2011). Neurobiology of Depression. CRC Press. p. 458. ISBN 978-1-4398-3849-5. Retrieved 28 April 2012.